Hyper Corporation Inc. Stock

Equities

A065650

KR7065650004

Computer Hardware

End-of-day quote Korea S.E. 06:00:00 2024-06-10 pm EDT 5-day change 1st Jan Change
1,409 KRW -0.07% Intraday chart for Hyper Corporation Inc. -1.19% +43.34%
Sales 2019 17.41B 12.64M Sales 2020 31.41B 22.81M Capitalization 148B 108M
Net income 2019 -1.78B -1.29M Net income 2020 -3.52B -2.56M EV / Sales 2019 7.38 x
Net cash position 2019 9.93B 7.21M Net cash position 2020 10.9B 7.92M EV / Sales 2020 4.37 x
P/E ratio 2019
-78.3 x
P/E ratio 2020
-39.8 x
Employees 33
Yield 2019 *
-
Yield 2020
-
Free-Float 86.3%
More Fundamentals * Assessed data
Dynamic Chart
Hyper Corporation Inc. completed the acquisition of unknown minority stake in Fingerlabs Co., Ltd. from FSN Co., Ltd. and AdQUA Interactive Inc. CI
AdQUA Interactive Inc. completed the acquisition of 48% stake in Emotion Global, Inc. from Medifron DBT Co., Ltd.. CI
Medifron DBT Co., Ltd. completed the acquisition of 19.49% stake in Makeus Co.,Ltd. from FSN Co., Ltd.. CI
Medifron DBT Co., Ltd. announced that it has received KRW 20.999999826 billion in funding from FSN Co., Ltd. CI
Medifron DBT Co., Ltd. agreed to acquire 31.8% stake in Fingerlabs Co., Ltd. from FSN Co., Ltd.. CI
AdQUA Interactive Inc. agreed to acquire 48% stake in Emotion Global, Inc. from Medifron DBT Co., Ltd. for KRW 5.9 billion. CI
Medifron DBT Co., Ltd. agreed to acquire 19.49% stake in Makeus Co.,Ltd. from FSN Co., Ltd. for KRW 7.9 billion. CI
FSN Co., Ltd., AI Tech Fund, Asset Plus Fund and Open Innovation Fund managed by Benex Investment completed the acquisition of a 22.4% stake in Medifron DBT Co., Ltd. from Hansung Cleantech Co., Ltd. and T Scientific Co.,Ltd. CI
EN Creative Co., Ltd. agreed to acquire HMR business of Medifron DBT Co., Ltd. for KRW 5.7 billion CI
Medifron DBT Co., Ltd. announced that it expects to receive KRW 41.999999652 billion in funding CI
Medifron DBT Co., Ltd. announced that it expects to receive KRW 20.999999826 billion in funding from FSN Co., Ltd. CI
Medifron DBT Co., Ltd. announced that it has received KRW 4.0000092 billion in funding from T Scientific Co.,Ltd CI
Medifron DBT Co., Ltd.(KOSDAQ:A065650) dropped from S&P Global BMI Index CI
Medifron DBT Co., Ltd. announced that it has received KRW 3 billion in funding CI
Medifron DBT Co., Ltd. announced that it expects to receive KRW 3 billion in funding CI
More news
1 day-0.07%
1 week-1.19%
Current month-2.96%
1 month-6.69%
3 months+16.64%
6 months+40.34%
Current year+43.34%
More quotes
1 week
1 380.00
Extreme 1380
1 436.00
1 month
1 340.00
Extreme 1340
1 590.00
Current year
956.00
Extreme 956
1 697.00
1 year
920.00
Extreme 920
2 565.00
3 years
920.00
Extreme 920
3 615.00
5 years
920.00
Extreme 920
6 600.00
10 years
920.00
Extreme 920
9 900.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 51 -
Comptroller/Controller/Auditor 57 -
Corporate Officer/Principal 57 18-03-26
Members of the board TitleAgeSince
Chief Executive Officer 51 -
Director/Board Member 52 -
Director/Board Member 42 -
More insiders
Date Price Change Volume
24-06-11 1,409 -0.07% 62,390
24-06-10 1,410 +0.28% 213,972
24-06-07 1,406 +0.14% 144,767
24-06-05 1,404 -1.54% 139,007
24-06-04 1,426 -0.28% 355,231

End-of-day quote Korea S.E., June 10, 2024

More quotes
Hyper Corporation Inc, formerly Medifron DBT Co Ltd, is a Korea-based company primarily engaged in the manufacture and sale of information and communication devices. The Company operates through three segments. The Information and Communication Technology Business segment is engaged in the manufacture and sale of gaming mice, gaming monitors, televisions, routers, and gaming devices. The Home Meal Replacement segment is engaged in the manufacture and supply of convenient meals. The New Drug Business segment is engaged in the development and sales of Alzheimer's treatments, non-narcotic painkillers, and early diagnosis kits for dementia.
More about the company
  1. Stock Market
  2. Equities
  3. A065650 Stock